EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Systems validation for parenteral clinical drugs application to research and development and quality control laboratories






Journal of Parenteral Science & Technology 37(2): 45-50

Systems validation for parenteral clinical drugs application to research and development and quality control laboratories

The production of parenteral products for clinical use represents unique burdens and problems for quality control [QC] and research and development laboratories [R and D] involved in product development. Since the application of GMP [Good Manufacturing Practices] to QC and R and D laboratory operations is frequently the subject of controversy, this presentation attempts to discuss the FDA [USA Food and Drug Administration] position on this matter. While the FDA does consider that GMP do apply to QC and R and D laboratories involved in clinical drug development, it is recognized that there are legitimate questions about which systems need to be validated and to what degree. The rationale or need for validation is emphasized, and recent FDA experiences are utilized to illustrate problem areas. Some R and D and QC systems for which validation should be considered/required are identified.


Accession: 006575809



Related references

Tetzlaff, R.F., 1983: Systems validation for parenteral clinical drugs--application to R&D and QC laboratories. Journal of Parenteral Science and Technology 37(2): 45-50

Sweep, F.C.G.J.; Fritsche, H.A.; Gion, M.; Klee, G.G.; Schmitt, M., 2003: Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: an EORTC-NCI working group report. A major dilemma associated with immuno(metric) assays for biomarkers is that various kits employing antibodies with differing specificities and binding affinities may generate non-equivalent test results. Also, variation in sample processing and t...

Tonks, D.B., 1963: Quality Control Systems In Clinical Chemistry Laboratories. Postgraduate Medicine 34: A58-A70

Müller-Oerlinghausen, B.; Riedel, E., 1979: Simultaneous determination of antiepileptic drugs in clinical laboratories: Problems of quality control and standardization. Methods for determination of antiepileptic drugs in clinical laboratories are discussed with respect to precision, constant error control and economy. Experimental data for reproducibility and standardization are presented for gas chromatographic...

Chen, M-Shu.; Wu, M-Hsun.; Lin, C-Ming., 2014: Application of indices Cp and Cpk to improve quality control capability in clinical biochemistry laboratories. The traditional criteria for acceptability of analytic quality may not be objective in clinical laboratories. To establish quality control procedures intended to enhance Westgard multi-rules for improving the quality of clinical biochemistry tests...

Mueller Oerlinghausen B.; Riedel E., 1979: Simultaneous determination of anti epileptic drugs in clinical laboratories under routine conditions problems of quality control and standardization. Methods for determination of antiepileptic drugs [in human serum] in clinical laboratories are discussed with respect to precision, constant error control and economy. Experimental data for reproducibility and standardization are presented for gas...

Emanuel', A.V.; Ivanov, G.A.; Fleganova, I.N.; Emanuel', V.L., 2013: The practice of development and implementation of quality management systems in medical laboratories. The GOST R ISO 15189-2009 "medical laboratories. The detailed requirements to quality and competence". Particular difficulties of global nature. The article discusses the methodological issues related to the implementation of international principles of standardization in the format of GOST R ISO 9001-2008 "Quality management systems. Requirements", GOST R ISO 15189-2009 "Me...

Likhtenshteĭn, I.E.; Bazarnova, M.A.; Evstratova, I.N., 1979: Quality control and the standardization of laboratory research methods is the basic way to improve the performance of clinical diagnostic laboratories. Laboratornoe Delo: 135-137

Jansen, R.T.; Blaton, V.; Burnett, D.; Huisman, W.; Queralto, J.M.; Allman, B., 1997: European Communities Confederation of Clinical Chemistry: essential criteria for quality systems of medical laboratories. Working Group on Harmonisation of Quality systems and Accreditation. European Journal of Clinical Chemistry and Clinical Biochemistry 35(2): 123-132

Jansen, R.T.; Blaton, V.; Burnett, D.; Huisman, W.; Queraltó, J.M.; Zérah, S.; Allman, B., 1998: Additional Essential Criteria for Quality Systems of Medical Laboratories. European Community Confederation of Clinical Chemistry (EC4) Working Group on Harmonisation of Quality Systems and Accreditation. Essential Criteria for Quality Systems of Medical Laboratories have been published recently by the European Community Confederation of Clinical Chemistry (EC4) Working Group on Harmonisation of Quality Systems and Accreditation. The Essential Crit...